IDENTIFICATION OF 5-HYDROXYTRYPTAMINE(10) BINDING-SITES IN SHEEP CAUDATE-NUCLEUS MEMBRANES

被引:4
作者
PAUWELS, PJ
PALMIER, C
BRILEY, M
机构
[1] Laboratory of Cellular Neurobiology Division, Neurobiology I Centre de Recherche Pierre Fabre Castres
关键词
D O I
10.1016/0006-2952(93)90531-Z
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Radioligand binding measurements were performed in membranes of sheep caudate nucleus using [H-3]5-hydroxytryptamine (5-HT). [H-3]5-HT labeled a population of high affinity binding sites with a K(d) of 1.9 +/- 0.1 nM and a B(max) of 19.8 +/- 2.2 fmol/mg tissue. Combined 5-HT1D/E binding sites were the predominant 5-HT, subtype, accounting for 78% of the total population of 5-HT1 binding sites. 5-Carboxamidotryptamine (5-CT) and sumatriptan yielded inhibition curves which best fitted a two-site model with high affinity values of 0.8 and 10. 1 nM, and 1000 and 206 nM for their low affinity components. The proportion of the high affinity 5-CT and sumatriptan binding sites was 79 and 72%. The binding affinity profile of 5-HT1D binding sites [5-CT > 5-HT > d-LSD > 5-MeOT > sumatriptan > RU 24,969 > metergoline > tryptamine = rauwolscine = methylsergide > yohimbine = methiothepin > TFMPP = 8-OH-DPAT > 2-methyl-5-HT > mCPP = quipazine = CP 93,129 > ketanserin > (-)-propranolol = haloperidol = ipsapirone] compares well to that reported for 5-HT1D receptor sites in human caudate and cortex (correlation coefficient: 0.99 and 0.98). The present results indicate that sheep caudate nucleus is a valid tissue for studying interaction of compounds with 5-HT1D binding sites in the relative absence of 5-HT1E binding sites.
引用
收藏
页码:535 / 538
页数:4
相关论文
共 15 条
[1]   AN INVESTIGATION OF THE 5-HT1D RECEPTOR-BINDING AFFINITY OF 5-HYDROXYTRYPTAMINE, 5-CARBOXYAMIDOTRYPTAMINE AND SUMATRIPTAN IN THE CENTRAL-NERVOUS-SYSTEM OF 7 SPECIES [J].
BEER, MS ;
STANTON, JA ;
BEVAN, Y ;
CHAUHAN, NS ;
MIDDLEMISS, DN .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 213 (02) :193-197
[2]  
BRUINVELS AT, 1992, N-S ARCH PHARMACOL, V346, P243
[3]  
HEURING RE, 1987, J NEUROSCI, V7, P894
[4]   DETECTION OF A NOVEL SEROTONIN RECEPTOR SUBTYPE (5-HT1E) IN HUMAN-BRAIN - INTERACTION WITH A GTP-BINDING PROTEIN [J].
LEONHARDT, S ;
HERRICKDAVIS, K ;
TITELER, M .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (02) :465-471
[5]   THE DISTRIBUTION OF 5-HT1D AND 5-HT1E BINDING-SITES IN HUMAN BRAIN [J].
LOWTHER, S ;
DEPAERMENTIER, F ;
CROMPTON, MR ;
HORTON, RW .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 222 (01) :137-142
[6]   [H-3] 5-CARBOXAMIDOTRYPTAMINE LABELS MULTIPLE HIGH-AFFINITY 5-HT1D-LIKE SITES IN GUINEA-PIG BRAIN [J].
MAHLE, CD ;
NOWAK, HP ;
MATTSON, RJ ;
HURT, SD ;
YOCCA, FD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 205 (03) :323-324
[7]   QUANTITATIVE AUTORADIOGRAPHY OF 5-CT-SENSITIVE (5-HT1D) AND 5-CT-INSENSITIVE (5-HT1E) SEROTONIN RECEPTORS IN HUMAN BRAIN [J].
MILLER, KJ ;
TEITLER, M .
NEUROSCIENCE LETTERS, 1992, 136 (02) :223-226
[8]   LIGAND - A VERSATILE COMPUTERIZED APPROACH FOR CHARACTERIZATION OF LIGAND-BINDING SYSTEMS [J].
MUNSON, PJ ;
RODBARD, D .
ANALYTICAL BIOCHEMISTRY, 1980, 107 (01) :220-239
[9]   ACTIVITY OF SEROTONIN (5-HT)-RECEPTOR AGONISTS, PARTIAL AGONISTS AND ANTAGONISTS AT CLONED HUMAN 5-HT1A-RECEPTORS THAT ARE NEGATIVELY COUPLED TO ADENYLATE-CYCLASE IN PERMANENTLY TRANSFECTED HELA-CELLS [J].
PAUWELS, PJ ;
VANGOMPEL, P ;
LEYSEN, JE .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (02) :375-383
[10]   THE BINDING OF SEROTONERGIC LIGANDS TO THE PORCINE CHOROID-PLEXUS - CHARACTERIZATION OF A NEW TYPE OF SEROTONIN RECOGNITION SITE [J].
PAZOS, A ;
HOYER, D ;
PALACIOS, JM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (03) :539-546